Figure 1.
Figure 1. Survival, NRM, GVHD, and relapse. (A-G) Kaplan-Meier estimates of OS, DFS, and the cumulative incidence of NRM, acute GVHD grades II-IV and grades III-IV, extensive chronic GVHD, and relapse. Outcomes for the 72 patients with HLA-MMUDs are shown in red and for the 193 patients with HLA-MUDs are shown in blue. P values were calculated by using log-rank tests.

Survival, NRM, GVHD, and relapse. (A-G) Kaplan-Meier estimates of OS, DFS, and the cumulative incidence of NRM, acute GVHD grades II-IV and grades III-IV, extensive chronic GVHD, and relapse. Outcomes for the 72 patients with HLA-MMUDs are shown in red and for the 193 patients with HLA-MUDs are shown in blue. P values were calculated by using log-rank tests.

Close Modal

or Create an Account

Close Modal
Close Modal